16-2319591-C-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001089.3(ABCA3):​c.863G>A​(p.Arg288Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00703 in 1,612,206 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0063 ( 8 hom., cov: 31)
Exomes 𝑓: 0.0071 ( 80 hom. )

Consequence

ABCA3
NM_001089.3 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:6

Conservation

PhyloP100: 0.0120
Variant links:
Genes affected
ABCA3 (HGNC:33): (ATP binding cassette subfamily A member 3) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00830847).
BP6
Variant 16-2319591-C-T is Benign according to our data. Variant chr16-2319591-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 227155.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Uncertain_significance=3, Benign=1}.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ABCA3NM_001089.3 linkuse as main transcriptc.863G>A p.Arg288Lys missense_variant 8/33 ENST00000301732.10 NP_001080.2 Q99758-1Q4LE27

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ABCA3ENST00000301732.10 linkuse as main transcriptc.863G>A p.Arg288Lys missense_variant 8/331 NM_001089.3 ENSP00000301732.5 Q99758-1
ABCA3ENST00000382381.7 linkuse as main transcriptc.863G>A p.Arg288Lys missense_variant 8/321 ENSP00000371818.3 H0Y3H2
ABCA3ENST00000563623.5 linkuse as main transcriptn.1426G>A non_coding_transcript_exon_variant 8/201

Frequencies

GnomAD3 genomes
AF:
0.00632
AC:
961
AN:
152150
Hom.:
8
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00166
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.0118
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0110
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00567
AC:
1415
AN:
249708
Hom.:
9
AF XY:
0.00549
AC XY:
741
AN XY:
135006
show subpopulations
Gnomad AFR exome
AF:
0.00135
Gnomad AMR exome
AF:
0.00243
Gnomad ASJ exome
AF:
0.00873
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000653
Gnomad FIN exome
AF:
0.00499
Gnomad NFE exome
AF:
0.00934
Gnomad OTH exome
AF:
0.00653
GnomAD4 exome
AF:
0.00711
AC:
10373
AN:
1459942
Hom.:
80
Cov.:
35
AF XY:
0.00711
AC XY:
5161
AN XY:
726252
show subpopulations
Gnomad4 AFR exome
AF:
0.00119
Gnomad4 AMR exome
AF:
0.00268
Gnomad4 ASJ exome
AF:
0.0102
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000707
Gnomad4 FIN exome
AF:
0.00536
Gnomad4 NFE exome
AF:
0.00831
Gnomad4 OTH exome
AF:
0.00613
GnomAD4 genome
AF:
0.00631
AC:
961
AN:
152264
Hom.:
8
Cov.:
31
AF XY:
0.00564
AC XY:
420
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.00166
Gnomad4 AMR
AF:
0.00327
Gnomad4 ASJ
AF:
0.0118
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00471
Gnomad4 NFE
AF:
0.0110
Gnomad4 OTH
AF:
0.00190
Alfa
AF:
0.00948
Hom.:
15
Bravo
AF:
0.00556
TwinsUK
AF:
0.00539
AC:
20
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00826
AC:
71
ExAC
AF:
0.00592
AC:
719
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00834
EpiControl
AF:
0.00741

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 26, 2020This variant is associated with the following publications: (PMID: 30413314, 24871971, 29255193, 26928390, 23166334, 27374344, 27516224, 16728712, 20981092, 22995991, 22304854, 25073622) -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsFeb 27, 2017- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenOct 01, 2023ABCA3: BP4, BS2 -
Interstitial lung disease due to ABCA3 deficiency Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Uncertain significance, criteria provided, single submitterclinical testingGenetics and Molecular Pathology, SA PathologyJan 05, 2021- -
Uncertain significance, criteria provided, single submitterclinical testingJohns Hopkins Genomics, Johns Hopkins UniversitySep 24, 2019This ABCA3 variant (rs117603931) reaches polymorphic frequency (greater or equal than 1%) within the European (non-Finnish) subpopulation in large population datasets (gnomAD: 1324/129014 total alleles; 1.03%; 11 homozygotes). Two submitters in ClinVar classify this variant as likely benign. This variant was previously reported as a potential disease-associated variant, however, in both cases it was located on the same chromosome (in cis) as a second, likely more deleterious ABCA3 variant. Two bioinformatic tools queried predict that this substitution would be tolerated, and the arginine residue at this position is not evolutionarily conserved across the species assessed. Multiple studies suggest that this variant may impact the function of ABCA3. Per our review and consultation with a clinical expert, this variant may contribute to an increased risk of neonatal respiratory distress in combination with other genetic and environmental factors. The clinical significance of c.863G>A is uncertain at this time. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 15, 2015p.Arg288Lys in exon 8 of ABCA3: This variant is not expected to have clinical si gnificance because it has been identified in 0.95% (642/67532) of European chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs117603931). In addition, multiple mammals (>10) carry a lysine (Lys) a t this position, supporting that this change is tolerated. While this variant ha s been reported in 2 individuals with pulmonary disease (Brasch 2006, Copertino 2012), its frequency in the general population and presence of the variant amino acid in multiple mammals supports that this variant is not likely a primary cau se of disease. -
Hereditary pulmonary alveolar proteinosis Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 02, 2017This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
0.62
DANN
Benign
0.59
DEOGEN2
Benign
0.17
T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.71
T;T
M_CAP
Benign
0.044
D
MetaRNN
Benign
0.0083
T;T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
-0.050
N;.
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.67
N;N
REVEL
Uncertain
0.47
Sift
Benign
1.0
T;T
Sift4G
Benign
0.98
T;T
Polyphen
0.0
B;.
Vest4
0.26
MVP
0.52
MPC
0.23
ClinPred
0.00055
T
GERP RS
-5.4
Varity_R
0.033
gMVP
0.59

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs117603931; hg19: chr16-2369592; COSMIC: COSV57050489; COSMIC: COSV57050489; API